J&J unites with patient groups on lung cancer care decisions
December 12, 2025 | 09:40
The collaboration aims to strengthen shared decision-making processes between patients and clinicians across the Asia Pacific region.
Lung cancer breakthroughs take centre stage at medical conference
October 11, 2025 | 14:00
Medical experts gathered in Ho Chi Minh City for Asian Lung Cancer Conference 2025, focusing on early detection, advanced therapies, and international collaboration.
IBI363 earns second breakthrough therapy status for lung cancer in China
June 05, 2025 | 08:00
Innovent’s novel bispecific antibody shows promise for hard-to-treat NSCLC.
Innovent updates IBI363 data in advanced lung cancer at ASCO
June 04, 2025 | 08:00
New Phase 1 results underscore promise of the first-in-class bispecific antibody.
Ivonescimab Approved in China as First-Line Treatment for PD-L1+ Lung Cancer
April 26, 2025 | 14:29
A groundbreaking Phase III trial shows superior results to pembrolizumab, redefining NSCLC treatment.
AstraZeneca advances lung cancer portfolio
September 15, 2023 | 09:00
AstraZeneca showcased its lung cancer portfolio at the 2023 World Conference on Lung Cancer (WCLC) that was held in Singapore from September 9 to 12.
Lung cancer screening saves lives in Vietnam and Asia
July 28, 2023 | 20:35
Early diagnosis through improved screening access and changes to how people are screened is critical to reduce lung cancer deaths in Vietnam and Asia.
Mobile Version